Collegium Pharmaceutical Inc

NASDAQ:COLL   3:59:59 PM EDT
17.95
-0.84 (-4.47%)
Other Pre-Announcement

Collegium Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 20:58 GMT
Collegium Pharmaceutical Inc (COLL) - Collegium Reports Second Quarter 2022 Financial Results.
Q2 Revenue $123.5 Million.
Qtrly Loss per Share $0.15.
Sees FY Total Adjusted EBITDA of $245.0 Million to $255.0 Million.